arrow
A

Agnihotram V. Ramanakumar

University of Alberta
H指数:35
被引数:4,560

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparison of 90-day morbidity and mortality between ileal conduit and orthotopic neobladder following radical cystectomy in a large, multi-institutional database The Canadian CBCis experience

在大型多机构数据库中比较根治性膀胱切除术后回肠导管和原位新膀胱的90天发病率和死亡率:加拿大CBCis研究经验

2026-01-010
PRE
Investigating the Pre-Implementation Facilitators and Barriers of the Implementation of the Fear of Recurrence Therapy (FORT) Intervention in Canadian Cancer Centers

调查复发恐惧疗法(FORT)干预措施在加拿大癌症中心实施前的促进因素和阻碍因素

2025-10-070
OAAI
Metabolic factors drive early increase in hepatic steatosis despite improvement in non-invasive fibrosis markers after hepatitis C eradication with direct-acting antivirals

代谢因素驱动早期肝脂肪变性增加,尽管在直接抗病毒药物清除丙型肝炎后非侵入性纤维化标志物有所改善

2025-06-160
PRE
Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Human Papillomavirus-Related Oropharyngeal Cancer
2025-02-010
PRE
Prognostic value of non-invasive scores based on liver stiffness measurement, spleen diameter and platelets in HIV-infected patients
2023-05-151
OAAI
Fibroscan-Aspartate Aminotransferase (FAST) Score Predicts Liver-Related Outcomes, but Not Extrahepatic Events, in a Multicenter Cohort of People With Human Immunodeficiency Virus
2023-04-048
PRE
Fear of Cancer Recurrence Therapy (FORT): A Randomized Controlled Trial
2023-03-0112
PRE
Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000-2014 (CONCORD-3)
2022-11-1020
OAAI
Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study
2020-12-0915
OAAI
Human papillomavirus testing versus cytology in primary cervical cancer screening: End-of-study and extended follow-up results from the Canadian cervical cancer screening trial

原发性宫颈癌筛查中人乳头瘤病毒检测与细胞学检查的比较: 加拿大宫颈癌筛查试验的研究结束和扩展随访结果

2016-08-3053
OAAI